For over 16 years, PHARMExcel and Moorfields Eye Hospital have collaborated to push the boundaries of ophthalmology clinical research. This partnership combines Moorfields’ world-class expertise and cutting-edge technology with PHARMExcel’s excellence in clinical trial delivery. Together, we’re improving patient outcomes and setting new standards in eye care, making significant strides in the fight against eye diseases and disorders.
Discover how this visionary alliance is transforming ophthalmology research and contributing to global healthcare advancements.
Moorfields Eye Hospital is home to some of the most renowned ophthalmologists, researchers, and clinicians globally. Their expertise spans a wide range of eye conditions, from common issues like cataracts and glaucoma to rare genetic disorders. Working with experts that have such a breadth of knowledge and experience ensures that PHARMExcel’s clinical trials are guided by the latest scientific insights and best practices.
Moreover, Moorfields’ is at the forefront of innovation. The hospital’s collaboration with leading technology companies, such as its work with DeepMind on AI-driven retinal disease detection, demonstrate its commitment to integrating cutting-edge technologies into clinical research. These innovations not only improve patient outcomes but also set new standards in the field.
Moorfields Eye Hospital, London UK
One of the most significant advantages of partnering with Moorfields’ is our access to an extensive and diverse patient base. Moorfields’, with over 750,000 patient visits each year, serves a broad spectrum of individuals across various age groups, ethnicities, and socio-economic backgrounds. This vast and varied patient pool is a critical asset for conducting clinical research on a wide range of eye conditions, from common issues like glaucoma and cataracts to rare and complex genetic disorders.
The diversity within Moorfields’ patient population is particularly valuable for our clinical trials. In research, diversity ensures that the findings are robust, comprehensive, and applicable to the general population, rather than skewed toward a particular demographic. This inclusivity is essential for developing treatments that are effective across different population groups, leading to more equitable healthcare outcomes.
Beyond the diversity of conditions and demographics, Moorfields’ strong and established patient network significantly enhances the efficiency of patient recruitment—a process often cited as one of the most challenging aspects of clinical research in particularly with ocular studies. Recruiting sufficient numbers of participants who meet specific criteria is essential for ensuring that our studies produce meaningful data.
By leveraging Moorfields’ extensive reach, our team can more easily identify and enrol eligible participants, reducing the time and resources typically required for recruitment. The hospital’s reputation and trust within the community further bolster recruitment efforts, as patients are more likely to participate in studies conducted by an institution known for its excellence in eye care. This trust translates into higher participation rates and better retention, ensuring that our clinical trials proceed smoothly and efficiently.
Additionally, Moorfields’ specialised clinics and dedicated research units are adept at managing the recruitment and follow-up of trial participants. This targeted recruitment approach not only speeds up the enrolment process but also enhances the quality of the data collected, as participants are more likely to adhere to study protocols and remain engaged throughout the trial.
who
Moorfields is not just a hospital; it’s a comprehensive research institution with state-of-the-art facilities dedicated to ophthalmic research. The hospital is closely affiliated with the UCL Institute of Ophthalmology, one of the world’s leading centres for vision research. Consequently Moorfields has amassed one of the world’s largest databases of ophthalmic data to augment cutting edge-research. The Moorfields Ophthalmic Reading Centre & Clinical AI Lab is a state of the art image grading centre for clinical trials and serves as Moorfield’s data analysis hub..
Moorfields Reading Centre, London UK
Contract Research Organisations (CROs) play a pivotal role in managing and executing clinical trials. Choosing a CRO like PHARMExcel that has an established partnership with Moorfields Eye Hospital, combined with its own in-house clinical trial delivery teams who have a deep understanding of ophthalmic studies, can provide significant advantages for any clinical research project in this therapeutic space.
PHARMExcel’s established connections to Moorfields’ brings the added CRO benefit of seamless access to the hospital’s world-class expertise and resources. This longstanding relationship allows us to tap into the latest clinical knowledge, utilise state-of-the-art facilities, and engage with leading ophthalmologists in the UK and through Moorfields overseas facilities in Singapore and Dubai. This is particularly beneficial when designing robust clinical trials, optimising study protocols, and ensuring that trials are aligned with the highest standards of care.
Patient recruitment and retention are often challenging aspects of clinical trials. A CRO linked with Moorfields’ can leverage the hospital’s vast and diverse patient base, making recruitment more efficient and targeted. Moreover, the trust and reputation associated with Moorfields’ can improve patient confidence and willingness to participate, thereby enhancing retention rates throughout the trial.
The ultimate goal of clinical research is to translate findings into practical treatments that benefit patients. A CRO with ties to Moorfields’ and the Institute of Ophthalmology is well-positioned to accelerate this process, thanks to both the Institute and hospital’s proven track record in translating research from bench to bedside. This collaboration ensures that new therapies and innovations developed during the trial can be rapidly tested and implemented in real-world clinical settings, maximising the impact of the research.
Moorfields Eye Hospital offers unparalleled advantages for clinical research in ophthalmology: From world-class expertise and a diverse patient population to cutting-edge infrastructure and a commitment to translational research. By collaborating with a CRO such as PHARMExcel, that has a successful long-term relationship with Moorfields, will amplify the capabilities of your trial, providing a streamlined, efficient, and highly effective pathway. We look forward to continuing our partnership with Moorfields for early phase and experimental medicine studies.
Phase I Novel Treatment
One of the largest clinical studies of patients with Birdshot Uveitis (eye disease) in the UK running at Moorfields Eye Hospital and University Hospital Birmingham.
Non-Interventional Study
Distance Of Choroid Study-DOCS Study
Conducted at Moorfields Eye Hospital, recruiting patients with neovascular age-related macular degeneration (nAMD).
Epigenetics Study
Single centre study run at Moorfields Eye Hospital to evaluate the immune mechanism of inflammatory eye diseases.
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Media Contact
Katie Howe, Head of Marketing
E: katie.howe@pharmexcel-cro.com
T: +44 (0)20 3642 6654
